Latest News & Articles
Browse all our latest news articles and stories
FAQ: CNS Pharmaceuticals' Participation in the 2024 SNO/ASCO CNS Cancer Conference
CNS Pharmaceuticals (NASDAQ: CNSP) will present its research on Berubicin, a novel treatment for brain and CNS cancers, at the 2024 SNO/ASCO CNS …
August 27, 2024
Source
FAQ on Clene's CNM-Au8(R) and Gold Nanocrystal Technology Developments
Clene (NASDAQ: CLNN) is advancing its gold nanocrystal technology, CNM-Au8(R), for treating neurodegenerative diseases like ALS and MS, with Phase 3 …
August 27, 2024
Source
FAQ: Mullen Automotive's Order for Campus EVs by DB Schenker
Mullen Automotive has received an order for four Campus EVs from DB Schenker for use in mail and delivery services on Intel's technology campus in …
August 27, 2024
Source
FAQ on CNS Pharmaceuticals' Exclusive License Agreement for GBM Treatment
CNS Pharmaceuticals has entered an exclusive license agreement with Cortice Biosciences Inc. to develop TPI 287, a potential treatment for …
August 27, 2024
Source
FAQ: Cepton's Acquisition by Koito Manufacturing Co. Ltd.
Cepton, a leader in high-performance lidar solutions, has entered a definitive agreement to be acquired by Koito Manufacturing Co. Ltd., a move …
August 27, 2024
Source
D-Wave Quantum's Expansion into Quantum AI Solutions: Key FAQs
D-Wave Quantum Inc. (NYSE: QBTS) is enhancing its Leap quantum cloud service to integrate quantum optimization with AI and ML, aiming to revolutionize …
August 27, 2024
Source
SenesTech CEO Featured on The GotStocks Podcast: Fertility Control for Pest Management
SenesTech, a leader in fertility control for managing animal-pest populations, was featured on The GotStocks Podcast, where CEO Joel Fruendt discussed …
August 27, 2024
Source
FAQ on InMed Pharmaceuticals' Long-Term Study Results for Alzheimer’s Disease Treatment
InMed Pharmaceuticals reports positive long-term study results for INM-901, a potential treatment for Alzheimer’s disease, showing improvements in …
August 27, 2024
Source
FAQ: Mullen Automotive's Participation at the 2024 SEUS-CP Business Forum
Mullen Automotive, an emerging EV manufacturer, is set to participate as an Anchor Organization and panelist at the 2024 SEUS-CP Business Forum in …
August 27, 2024
Source
FAQ on D-Wave Quantum Inc.'s Q2 2024 Financial Results Announcement
D-Wave Quantum Inc. (NYSE: QBTS) will release its Q2 2024 financial results on August 8, 2024, before the market opens, followed by a conference call …
August 27, 2024
Source
HeartBeam Q2 2024 Results Conference Call and Webcast FAQ
HeartBeam Inc. (NASDAQ: BEAT) has announced a conference call and webcast to discuss its second-quarter 2024 results, featuring insights from company …
August 27, 2024
Source
FAQ on SenesTech's Non-Lethal Rodent Pest Management Solutions and Their Impact on Wildlife
SenesTech offers a non-lethal alternative to rodenticides, which have been found to harm birds of prey and other wildlife, by providing EPA-registered …
August 27, 2024
Source
FAQ on SuperCom's Role in Domestic Violence Prevention Through Electronic Monitoring
SuperCom Ltd. (NASDAQ: SPCB) is leveraging its PureSecurity Suite platform to address domestic violence prevention by enforcing protective orders …
August 27, 2024
Source
FAQ: Mullen Automotive's New bizEV Lease Program for the Mullen ONE EV Cargo Van
Mullen Automotive introduces bizEV, a turnkey lease program for its Mullen ONE Class 1 EV cargo van, aimed at individuals, small businesses, and …
August 27, 2024
Source
HeartBeam Q2 2024 Results Conference Call and Webcast FAQ
HeartBeam, a medical technology company, has announced a conference call and webcast to discuss its second-quarter 2024 results, featuring insights …
August 27, 2024
Source
FAQ on Clene's Participation in the Canaccord Genuity 44th Annual Growth Conference
Clene Inc., a clinical-stage biopharmaceutical company, is set to present at the Canaccord Genuity 44th Annual Growth Conference, highlighting its …
August 27, 2024
Source
SenesTech Q2 2024 Financial Results Announcement FAQ
SenesTech (NASDAQ: SNES) will host a conference call and webcast on Aug. 8, 2024, to discuss its Q2 2024 financial results, showcasing its leadership …
August 27, 2024
Source
Annovis Bio's CEO Discusses Breakthroughs in Neurodegenerative Disease Treatment on Bell2Bell Podcast
Annovis Bio's CEO, Dr. Maria Maccecchini, shared insights on the promising phase 3 results of buntanetap for Parkinson's disease and its potential …
August 27, 2024
Source
Mullen Automotive (NASDAQ: MULN) Shares Update and Future Growth FAQ
Mullen Automotive, an emerging EV manufacturer, provided an update from CEO David Michery highlighting the company's strong foundation for future …
August 27, 2024
Source
